Post-authorization Observational Study to Evaluate Cognition and Fatigue in RRMS Patients Treated With Rebif.
Phase of Trial: Phase IV
Latest Information Update: 05 Sep 2013
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms SKORE
- Sponsors Merck KGaA
- 05 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2011 Actual initiation date (May 2009) added as reported by ClinicalTrials.gov.
- 30 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.